Skip to main content

More of the same in H2, says FXB, as Groupama targets strategic shift

boisseau-francois-xavier

Groupama chief executive François-Xavier Boisseau has dismissed suggestions that the divestment of the firm's UK broking arm is likely to significantly dent the future financial performance of the business.

Speaking to Post this afternoon after releasing the insurer's first half results, Boisseau insisted that the strategic shift towards niche and specialist lines will have a greater bearing on the firm

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Throwback Thursday: Biba’s talent help

Insurance Post’s Throwback Thursday steps back in time to September 1981 to remind you what was going on this week in insurance history when the British Insurance Brokers’ Association responded to demand from members for help with “personnel matters.”

McGill sold to EQT for $2bn

McGill and Partners and private equity firm EQT have entered into a definitive agreement in which the latter will acquire a majority stake in the former for $2bn (£1.5m).

AI in broking: why the debate must move on

For insurance brokers, Andy Lewis, head of people proposition at Hedron Network, says the artificial intelligence debate has shifted from whether to adopt the technology to how to embed it safely, practically and strategically so it delivers lasting value.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here